A newly NHS-approved weight loss drug, Mounjaro, is being blamed for the tragic death of a 58-year-old Scottish nurse after ...

Tensions had been mounting in the Dutch capital over Israel’s campaigns in Gaza and Lebanon, even before the Europa League ...

Denmark-based Novo Nordisk teased some new details about a potential Ozempic successor during a call with investors on Tuesday. Sales of the company’s current blockbuster weight loss drug, Wegovy, ...

Danish pharmaceutical giant Novo Nordisk sees a significant increase in profits and sales despite production constraints.

3️⃣ Poignant postcard: In 1912, a first-class passenger on the Titanic scrawled a message in pencil to someone back home in ...

Danish pharmaceutical giant Novo Nordisk, maker of the blockbuster diabetes and weight-loss drugs Ozempic and Wegovy, posted Wednesday strong third-quarter earnings despite being held back by ...

The FTSE 100 was 0.07% lower at 8,166, Germany's DAX down 1.14% at 19,036, France's CAC 0.51% lower at 7,369 and Italy's FTSE ...

Novo Nordisk reported forecast-beating quarterly sales of its popular Wegovy weight-loss drug on Wednesday, sending its shares up nearly 9%.

Novo Nordisk added 7.4% after the weight-loss and diabetes drugmaker reported better-than-expected quarterly sales of its ...

TODAY'S TOP HEADLINES Novo Nordisk's Blockbuster Wegovy Drug Sales Beat Expectations Novo Nordisk's blockbuster Wegovy weight-loss drug beat sales expectations in the third quarter, sending shares ...

AstraZeneca PLC shed £15 billion in market capitalization on Tuesday, after investors were underwhelmed by early data from a ...

While this move from Sanofi is not completely unprecedented, it did not go unnoticed and received considerable coverage, ...